Contemporary Trends and Outcomes Associated with the Pre-Procedural Use of Oral P2Y12 Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

OBJECTIVES: We sought to describe trends in the use of pre-procedural P2Y12 inhibitors and their clinical impact in patients undergoing percutaneous coronary intervention (PCI). BACKGROUND: Oral P2Y12 inhibitors are ubiquitously used medications; however, the specific timing of initial P2Y12 inhibit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Invasive Cardiol
Main Authors: Sukul, Devraj, Seth, Milan, Dixon, Simon R., Khandelwal, Akshay, LaLonde, Thomas A., Gurm, Hitinder S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5699908/
https://ncbi.nlm.nih.gov/pubmed/28420804
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados